Olarte M R, Shafer S Q
Neurology. 1985 Jul;35(7):1063-6. doi: 10.1212/wnl.35.7.1063.
Fifty-nine patients with amyotrophic lateral sclerosis participated in a 12-month, double-blind crossover trial. The patients were given either levamisole 150 mg or placebo in identical tablets once a week orally, and a rating of neurologic signs and symptoms was recorded on monthly visits. The patients were crossed over at 6 months. Levamisole had no effect on the rate of score decline in the 20 patients who completed the trial.
59例肌萎缩侧索硬化症患者参与了一项为期12个月的双盲交叉试验。患者每周口服一次外观相同的片剂，其中150毫克左旋咪唑或安慰剂，每月就诊时记录神经体征和症状评分。患者在6个月时进行交叉治疗。左旋咪唑对完成试验的20例患者的评分下降率没有影响。
